
+ $9.99 flat-rate shipping
High-capacity 30mg Retatrutide vial for extended triple-agonist research protocols. Targets GLP-1, GIP, and glucagon receptors simultaneously in studies of metabolic flexibility and body-composition pathways. ≥98% HPLC purity, lyophilized, with batch-specific Certificate of Analysis. Research use only.
Incretin-class research compounds that engage GLP-1 and related receptors, widely used in studies of glucose regulation, appetite pathways, and energy metabolism.
Retatrutide is used by qualified researchers to investigate pathways including:
Retatrutide is supplied as lyophilized (freeze-dried) powder. For research reconstitution, inject bacteriostatic water slowly down the inner wall of the vial and swirl gently — do not shake — until fully dissolved. Typical reconstitution volume is 1–3 mL depending on the research protocol and desired working concentration. Store lyophilized product at -20 °C; store reconstituted material at 2–8 °C and use within the stability window set by your laboratory.
Every batch of Retatrutide is analytically verified by an independent third-party laboratory for identity, purity, and potency. Certificates of Analysis are generated per batch and are accessible via the Batch Testing page or the Batch / COA tab above.
Retatrutide 30mg is supplied as a lyophilized powder in a sealed vial. For research use, reconstitute with bacteriostatic water (typically 1–3 mL depending on the research protocol) by injecting diluent slowly down the vial wall and gently swirling to dissolve. Do not shake. Store reconstituted material at 2–8 °C and use within the stability window established by your laboratory.
Each batch of Retatrutide is analytically tested by an independent third-party laboratory. Purity is verified to ≥98% (HPLC) for peptide and small-molecule products. A batch-specific Certificate of Analysis (COA) is available on every product page via the Batch / COA tab.
Store lyophilized vials at -20 °C, protected from light. After reconstitution, store at 2–8 °C and use within the stability window established by your protocol. Avoid repeated freeze-thaw cycles.
No. Retatrutide is sold for in-vitro and laboratory research use only by qualified researchers. It is not a drug, supplement, or consumer product and has not been evaluated by the FDA for the diagnosis, treatment, cure, or prevention of any disease or condition.